These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2895497)

  • 1. [Cardiac insufficiency. Current treatment].
    Aumont MC; Castaigne A
    Rev Prat; 1988 Feb; 38(5 Suppl):5-11. PubMed ID: 2895497
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of heart failure: update 1994.
    Krueger SK; Mahapatra S; Gangahar DM; Wilson CS; Turk KT; Vermaas PL
    Nebr Med J; 1994 Aug; 79(8):292-7. PubMed ID: 7990994
    [No Abstract]   [Full Text] [Related]  

  • 3. [Exercise test in the evaluation of the efficacy of drug therapy].
    Febo O; Cobelli F
    Ital Heart J Suppl; 2000 Mar; 1(3):393-9. PubMed ID: 10815269
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progress in the treatment of cardiac insufficiency].
    Perrenoud JJ
    Rev Med Suisse Romande; 1998 Jul; 118(7):625-30. PubMed ID: 9708019
    [No Abstract]   [Full Text] [Related]  

  • 5. Just the berries. Management of heart failure.
    Ruggles L
    Can Fam Physician; 2001 Mar; 47():499-501. PubMed ID: 11281082
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy and safety of chronic oral administration of xamoterol to patients with severe heart failure treated with ACE inhibitors.
    Pouleur H; Hanet C; Rousseau MF
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):82S-83S. PubMed ID: 2572263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of chronic cardiac failure in 1997: obvious facts and uncertainties].
    Komajda M
    Arch Mal Coeur Vaiss; 1997 Sep; 90(9):1205-7. PubMed ID: 9488765
    [No Abstract]   [Full Text] [Related]  

  • 8. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
    Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment].
    Novosel MK; Haghfelt TH
    Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure.
    McKelvie R
    Clin Evid; 2006 Jun; (15):118-39. PubMed ID: 16973007
    [No Abstract]   [Full Text] [Related]  

  • 11. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
    Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
    Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment guidelines for heart failure stress multidrug approach.
    Morey SS
    Am Fam Physician; 1999 Jun; 59(11):3265-6. PubMed ID: 10392599
    [No Abstract]   [Full Text] [Related]  

  • 13. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
    Ahmad T; Patel CB; Milano CA; Rogers JG
    Circulation; 2012 Jun; 125(23):2948-55. PubMed ID: 22689932
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assessment of chronotropic effect and arrhythmogenesis on beta 1-partial agonist (Xamoterol) in chronic heart failure].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    Kokyu To Junkan; 1988 Nov; 36(11):1227-33. PubMed ID: 2907820
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of xamoterol in heart failure of ischemic origin.
    Marlow HF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S69-72. PubMed ID: 2478814
    [No Abstract]   [Full Text] [Related]  

  • 17. [Progress in medical treatment of heart failure].
    López Mora E
    Arch Cardiol Mex; 2001; 71 Suppl 1():S95-101. PubMed ID: 11565355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of heart failure. Digitalis, diuretic plus ACE inhibitor or more?].
    Becker H; Sigmund M
    Internist (Berl); 1995 Dec; 36(12):1117-23. PubMed ID: 8567216
    [No Abstract]   [Full Text] [Related]  

  • 19. [The value of xamoterol in moderate ischemic cardiac insufficiency].
    Rousseau MF; Cheron P; Vincent MF; Pouleur H; Lavenne F
    Ann Cardiol Angeiol (Paris); 1984; 33(4):215-8. PubMed ID: 6147115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM; Arumugham P
    Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.